HARVARD BIOSCIENCE, INC. Stock Issued During Period, Value, Restricted Stock Award, Gross
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- HARVARD BIOSCIENCE, INC. stock issued during period, value, restricted stock award, gross for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- HARVARD BIOSCIENCE, INC. stock issued during period, value, restricted stock award, gross for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- HARVARD BIOSCIENCE, INC. stock issued during period, value, restricted stock award, gross for the quarter ending 2025-12-31 was $3.00K, a 57.14% decline year-over-year.
- HARVARD BIOSCIENCE, INC. stock issued during period, value, restricted stock award, gross for the quarter ending 2025-09-30 was $1.00K.
- HARVARD BIOSCIENCE, INC. stock issued during period, value, restricted stock award, gross for fiscal 2025 was $8.00K, a 0.00% change from fiscal 2024.
- HARVARD BIOSCIENCE, INC. stock issued during period, value, restricted stock award, gross for fiscal 2024 was $8.00K.
- HARVARD BIOSCIENCE, INC. stock issued during period, value, restricted stock award, gross for fiscal 2023 was $0.00.
- HARVARD BIOSCIENCE, INC. stock issued during period, value, restricted stock award, gross for fiscal 2022 was $0.00.
| Period end | Stock Issued During Period, Value, Restricted Stock Award, Gross 3 month | Stock Issued During Period, Value, Restricted Stock Award, Gross 12 month |
|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-11 | $4.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-12 | $6.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $8.00K 10-K · filed 2026-03-13 |
| 2025-09-30 | $1.00K 10-Q · filed 2025-11-06 | $11.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $2.00K 10-Q · filed 2026-08-11 | $10.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $1.00K 10-Q · filed 2026-05-12 | $9.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $8.00K 10-K · filed 2026-03-13 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $1.00K 10-Q · filed 2025-08-11 | $1.00K derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-12 | $0.00 derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $0.00 10-K · filed 2025-03-14 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $0.00 derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-08 | $0.00 derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-07 | $0.00 derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $0.00 10-K · filed 2024-03-07 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-07 | $0.00 derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-08 | $0.00 derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-04 | $0.00 derived: sum of 4 quarters · filed 2023-03-09 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $0.00 10-K · filed 2023-03-09 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-09 | $0.00 derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-04 | $0.00 derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-04 | $0.00 derived: sum of 4 quarters · filed 2022-05-04 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $0.00 10-K · filed 2022-03-11 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-05 | $0.00 derived: sum of 4 quarters · filed 2021-11-05 |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-06 | $0.00 derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-07 | $0.00 derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-03-17 | $0.00 10-K/A · filed 2021-03-17 |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $0.00 10-Q · filed 2020-08-10 | |
| 2019-03-31 | -$421.00K 10-Q · filed 2019-05-08 | |
| 2018-09-30 | $1.00K 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $3.00K 10-Q · filed 2019-08-08 | |
| 2018-03-31 | -$5.00K 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |